NEWS & EVENTS
Rivaroxaban receives draft NICE Guidance
National Institute for Health and Clinical Excellence issues draft guidance on Rivaroxaban the first once a day new oral anticoagulant for use in non-valvular atrial fibrillation
First new oral-anticoagulant in nearly 60 years, for stroke prevention in atrial fibrillation receives final guidance
The National Institute for Health and Clinical Excellence (NICE) has issued final guidance recommending the new oral anticoagulant, Pradaxa® (dabigatran etexilate) as an option for the prevention of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation (AF) and one or more risk factors. This decision means dabigatran must now be made available for use by the NHS and that patients have the right to receive it if clinicians deem it clinically appropriate.
New report unveils worrying truth that patients with AF are unaware of stroke risk - Leading charities call for change in the management of life-threatening condition
A new report launched by AntiCoagulation Europe (ACE) highlights that over half of UK patients diagnosed with AF are not aware of the condition’s life-threatening link to stroke. It also reveals that over half of these UK patients believe that their lives are more affected by their warfarin therapy to reduce risk of stroke than the condition itself.
Major report on Atrial Fibrillation launched by ACE.
A major source of information for patients and healthcare professionals on all aspects of AF, including urgent actions needed now to prevent untreated AF from causing a stroke epidemic.
Read the AF Report
Calculate your personal risk of stroke because of AF
Information for patients taking warfarin
Have you recently been prescribed warfarin and would like more information? For a beginners guide to warfarin please watch this short video. Video kindly created by Southampton University NHS Hospital Foundation Trust
SMC approves Rivaroxaban
On the 13th February 2012 The Scottish Medicines Consortium approved Rivaroxaban (Xarelto) for use in the prevention of stroke for patients with non-valvular atrial fibrillation and for the treatment of deep vein thrombosis and pulmonary embolism.
WELCOME TO ANTICOAGULATION EUROPE
INREVIEW MAGAZINE
We rely on donations and subscriptions so please consider joining or making a donation to enable us to coninue our work.
You can donate by clicking on to the link to right of this page. For easy ways to help us raise funds, at no cost to you, click on Give as You Live at the bottom of the page.
Home insurance, protect what makes your house a home.
Read more.
Sign our E-petition to get the government to debate free prescriptions for long term users of anticoagulation therapy
https://submissions.epetitions.direct.gov.uk/petitions/29914
Anticoagulation in Practice Conference 17th & 18th May in Birmingham
Designed for Health Care Professionals and Patients
To download programme and registration form click here
